Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Pharm Dev Technol. 2020 Feb 12;25(5):625–639. doi: 10.1080/10837450.2020.1725893

Figure 12.

Figure 12.

Plasma concentrations of ELQ-300 in male Sprague-Dawley rats administered ELQ-331 in two formulations. (Mean± SD; n=3). ELQ-331 levels were <LLOQ in plasma collected at all time points. SDD: Spray Dried Dispersion formulation of ELQ-331; SEDDS: Self-Emulsifying Drug Delivery System of ELQ-331.